Showing 6931-6940 of 9499 results for "".
- Arena Pharmaceuticals Announces First Subject Dosed in Phase 2 Trial Evaluating Etrasimod in Alopecia Areatahttps://practicaldermatology.com/news/arena-pharmaceuticals-announces-first-subject-dosed-in-phase-2-trial-evaluating-etrasimod-in-alopecia-areata/2460515/The first subject has been dosed in
- FirstDerm Launches @AutodermBothttps://practicaldermatology.com/news/firstderm-launches-at-autodermbot/2460479/
- Global Challenge Addresses Stigma and Bullying Associated with ADhttps://practicaldermatology.com/news/global-challenge-addresses-stigma-and-bullying-associated-with-ad/2460429/
- Cynosure Rolls Out Elite iQ Aesthetic Workstation For Laser Hair Removal, Skin Revitalizationhttps://practicaldermatology.com/news/cynosure-rolls-out-elite-iq-aesthetic-workstation-for-laser-hair-removal-skin-revitalization/2460407/
- Arena Completes Full Enrollment of Etrasimod Phase 2 ADVISE Trial for ADhttps://practicaldermatology.com/news/arena-completes-full-enrollment-of-etrasimod-phase-2-advise-trial-for-ad/2460403/
- NEA Announces 2020 Eczema Research Grant Cycle Openinghttps://practicaldermatology.com/news/nea-announces-2020-eczema-research-grant-cycle-opening/2460387/The
- Calling All Heroes: Cutera Seeks to Honor COVID-19 Championshttps://practicaldermatology.com/news/calling-all-heroes-cutera-seeks-to-honor-covid-19-champions/2460380/From physicians going back to the ER and conducting hospital rounds to supporting food depositories and shelters, to doctors donating personal protective equipment, ventilators, and office facilities as needed during the COVID-19 global pandemic, Cutera wants to shine a spotlight on its customers
- COVID-19 By the Numbers: April 28 Editionhttps://practicaldermatology.com/news/covid-19-by-the-numbers-april-28-edition/2460365/The CDC now lists nine potential symptoms of COVID-19, though cough and shortness of breath or difficulty breathing remain hallmarks of the disease. CDC says individuals may have COVID-19 if they experience these two symptoms plus at least two of the following: Fever
- LEO Pharma Enters License Agreement with Oneness Biotech, Microbio Shanghai for Atopic Dermatitis and Asthma Drug Candidatehttps://practicaldermatology.com/news/leo-pharma-enters-license-agreement-with-oneness-biotech-microbio-shanghai-for-atopic-dermatitis-and-asthma-drug-candidate/2460353/
- New Anti-Acne Launches from Ceravehttps://practicaldermatology.com/news/new-launches-from-cerave/2460236/CeraVe is rolling out